Amdocs (NASDAQ:DOX) Price Target Cut to $46.00 by Analysts at Stifel Nicolaus

Amdocs (NASDAQ:DOX) had its price objective decreased by Stifel Nicolaus from $71.00 to $46.00 in a research note released on Wednesday morning,Benzinga reports. Stifel Nicolaus currently has a buy rating on the technology company’s stock.

A number of other brokerages also recently issued reports on DOX. Oppenheimer downgraded Amdocs from an “outperform” rating to a “market perform” rating in a report on Wednesday. Weiss Ratings upgraded Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Finally, Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, August 29th. Three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $78.33.

Amdocs Price Performance

DOX stock opened at $43.66 on Wednesday. The stock has a market capitalization of $4.71 billion, a price-to-earnings ratio of 9.42, a PEG ratio of 1.00 and a beta of 0.42. The firm’s 50-day moving average price is $60.27 and its two-hundred day moving average price is $62.38. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. Amdocs has a 12-month low of $41.44 and a 12-month high of $85.63.

Amdocs (NASDAQ:DOX) last posted its earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.98. The company had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.19 billion. Amdocs had a net margin of 10.59% and a return on equity of 20.70%. Amdocs’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.83 earnings per share. As a group, equities analysts predict that Amdocs will post 7.12 earnings per share for the current year.

Amdocs Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a $0.5690 dividend. This represents a $2.28 annualized dividend and a dividend yield of 5.2%. The ex-dividend date of this dividend is Thursday, December 31st. Amdocs’s dividend payout ratio (DPR) is currently 54.29%.

Institutional Investors Weigh In On Amdocs

Large investors have recently modified their holdings of the stock. Royal Bank of Canada boosted its position in Amdocs by 14.9% during the 1st quarter. Royal Bank of Canada now owns 446,125 shares of the technology company’s stock valued at $29,114,000 after acquiring an additional 57,740 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of Amdocs by 429.6% in the 1st quarter. Renaissance Technologies LLC now owns 291,800 shares of the technology company’s stock worth $19,043,000 after acquiring an additional 236,700 shares in the last quarter. Arbejdsmarkedets Tillaegspension raised its position in shares of Amdocs by 17.5% in the 1st quarter. Arbejdsmarkedets Tillaegspension now owns 354,383 shares of the technology company’s stock worth $23,127,000 after acquiring an additional 52,906 shares in the last quarter. Steel Grove Capital Advisors LLC purchased a new position in shares of Amdocs in the 3rd quarter valued at approximately $2,229,000. Finally, TD Waterhouse Canada Inc. lifted its stake in shares of Amdocs by 14.1% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 247,521 shares of the technology company’s stock valued at $12,682,000 after purchasing an additional 30,555 shares during the period. Institutional investors own 92.02% of the company’s stock.

Trending Headlines about Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs announced an expanded collaboration with AT&T, which could support longer-term business opportunities. AT&T and Amdocs Expand Collaboration
• Positive Sentiment: The company agreed to acquire insurance software provider EIS for $340 million, a move that could diversify its business, though integration and execution risks remain. Amdocs acquires insurance tech firm EIS for $340 million
• Neutral Sentiment: Fiscal Q4 adjusted EPS of $1.98 and revenue of $1.19 billion matched analyst estimates; revenue grew 3.8% year over year. The in-line results offered little offset to concern about the outlook. Amdocs Meets Q4 Earnings Estimates
• Negative Sentiment: The T-Mobile contract dispute is the main catalyst for the selloff. Amdocs’ fiscal 2027 outlook reportedly allows for revenue to fall as much as 18%, including the possibility that its T-Mobile agreements end. Management has not detailed the company’s revenue exposure to T-Mobile, adding uncertainty. Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk
• Negative Sentiment: Several law firms announced investigations into potential securities-law violations related to alleged misrepresentations about the T-Mobile relationship. These are allegations under investigation, not findings of wrongdoing, but could add legal and reputational risk. Hagens Berman investigation
• Negative Sentiment: Analyst actions added pressure: Oppenheimer downgraded the stock to Perform, while Stifel cut its price target from $71 to $46, despite retaining a Buy rating.

About Amdocs

Amdocs Ltd. (NASDAQ: DOX) is a global provider of software and technology services for communications, media and entertainment companies. Its solutions help service providers manage customer relationships, billing, subscriptions, product offerings and digital experiences across consumer and enterprise markets.

The company’s portfolio includes business support systems and operational support systems, cloud-based software, artificial intelligence and automation tools, network and service management platforms, and solutions for media distribution and monetization.